Research Newswire

Live Results

1 - Penumbra Announces Worldwide Voluntary Field Removal of the Original Version of 6F Neuron 070 Delivery Catheter

ALAMEDA, Calif.-(Business Wire)-September 30, 2009 - Penumbra is initiating a voluntary Field Removal of the original version of Neuron 6F 070 Delivery Catheter. For these catheters, Penumbra has received feedback from some users that the catheter could kink or ovalize in certain anatomical...

2 - Idaho Technology Expands Its High Resolution Melting Patent Portfolio

SALT LAKE CITY-(Business Wire)-September 29, 2009 - Idaho Technology’s patent portfolio continues to grow as the U.S. Patent and Trademark Office granted the company U.S. Patent No. 7,582,429 relating to methods of performing genetic analysis in the presence of a double-stranded nucleic acid...

3 - MannKind to Present at the Fourth Annual JMP Securities Healthcare Focus Conference

VALENCIA, Calif.-(Business Wire)-September 29, 2009 - MannKind Corporation (Nasdaq: MNKD), focused on discovering, developing and commercializing treatments for diabetes and cancer, announced today that it will present at the Fourth Annual JMP Securities Healthcare Focus Conference on Tuesday...

4 - AZBio Announces Recipients of 2009 Awards

PHOENIX-(Business Wire)-September 29, 2009 - AZBio (Arizona BioIndustry Association) announced the winner of the association's annual awards, which were presented at the 2009 AZBio Awards Dinner, the largest annual gathering of Arizona's bioscience community, on Thursday, September 24th at the...

5 - SeraCare Life Sciences Awarded Multiple Contracts from the CDC and NIH to Support HIV Research and the Accuracy of HIV Testing

MILFORD, Mass.-(Business Wire)-September 29, 2009 - SeraCare Life Sciences, Inc. (NASDAQ: SRLS) today announced that the Company has been awarded two new contracts from the Centers for Disease Control (CDC) and the National Institutes of Health (NIH) and that a third existing contract has been...

6 - Intelligent Enterprise Solutions, Inc., is Hosting 3rd qPCR Symposium USA on 9-12 November at Millbrae, CA

SANTA CLARA, Calif.-(Business Wire)-September 29, 2009 - qPCR (Real-time quantitative PCR) has rapidly developed as the prime technology to detect and quantify nucleic acids in complex samples. It is used in the life science industry, healthcare, diagnostics, forensics, food, feed, agriculture, air...

7 - Cubist Pharmaceuticals Announces Enhanced Careers Section of Corporate Website

LEXINGTON, Mass.-(Business Wire)-September 29, 2009 - Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) is pleased to announce the re-launch of its corporate website and the introduction of the newly created Careers section. Our goal is to enhance the job seekers’ experience with both active and...

8 - New Clinical Data Shows AMS’ Minimally Invasive Treatment Options Effective at Restoring Female Pelvic Health

MINNETONKA, Minn.-(Business Wire)-September 29, 2009 - American Medical Systems® (AMS) (NASDAQ: AMMD), a leading provider of world-class devices and therapies for both male and female pelvic health, today announced the results of three major clinical studies that each point to a high degree of...

9 - VeriChip Corporation and RECEPTORS LLC Announce Further Details of Development Plan for Virus Triage Detection System for H1N1 Virus

DELRAY BEACH, Fla. & CHASKA, Minn.-(Business Wire)-September 29, 2009 - VeriChip Corporation (“VeriChip”) (NASDAQ: CHIP) and its development partner RECEPTORS LLC, a technology company whose AFFINITY by DESIGN™ chemistry platform can be applied to the development of selective binding...

10 - RegeneRx’s Tβ4 Significantly Improves Functional Recovery in Multiple Sclerosis Animal Model

BETHESDA, Md.-(Business Wire)-September 29, 2009 - REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) announced today that researchers at the Henry Ford Health System in Detroit, Michigan, demonstrated for the first time that Tβ4 treatment of EAE (experimental autoimmune encephalomyelitis – an...

11 - Axion’s Thermoplastic Technology Detailed in Research Paper Published by U.S. Army Corps of Engineers

BASKING RIDGE, N.J.-(Business Wire)-September 29, 2009 - Axion International Holdings, Inc. (OTCBB:AXIH), a next-generation technology innovator utilizing recycled plastic for high load industrial products, today announces the release of a research paper regarding high-load thermoplastic bridges...

12 - LifeCycle Pharma Announces Positive Results from a 12 Month Extension Phase of the Phase 2 Clinical Study of LCP-Tacro™ Once Daily in Stable Liver Transplant Patients

HØRSHOLM, Denmark-(Business Wire)-September 29, 2009 - LifeCycle Pharma A/S (CSE:LCP) today announced positive results from a completed 12 month extension phase of the Phase 2 clinical study of LCP-Tacro tablets in stable liver transplant patients. LCP-Tacro is a once daily immunosuppression drug...

13 - PolyMedix Initiates Dosing in Phase 1B Clinical Study of Novel Anticoagulant Antagonist Compound

RADNOR, Pa.-(Business Wire)-September 29, 2009 - PolyMedix, Inc. (OTC BB: PYMX, http://polymedix.com), an emerging biotechnology company developing new therapeutic drug products to treat infectious diseases and acute cardiovascular disorders based on biomimetics, has initiated dosing and commenced a...

14 - Top Life Sciences Attorney to Join Intrexon as Chief Legal Officer

BLACKSBURG, Va.-(Business Wire)-September 29, 2009 - Intrexon Corporation, a privately held life sciences company focused on modular DNA control systems for biotherapeutics and other industry sectors, today announced the appointment of Asher M. Rubin as Executive Vice President, Chief Legal Officer...

15 - CPRIT Announces Release of Two Prevention Funding Opportunities

AUSTIN, Texas-(Business Wire)-September 29, 2009 - The Cancer Prevention and Research Institute of Texas (CPRIT) has released its first two cancer prevention requests for applications (RFA) just six weeks after Rebecca Garcia, Ph.D. joined CPRIT’s leadership team as chief prevention officer...

16 - Luminex Corporation Hosts Seventh Annual Planet xMAP Europe

Luminex Corporation (NASDAQ: LMNX), the worldwide leader in multiplexed solutions, today announced that it will host Planet xMAP Europe 2009, its annual European multiplexing technology symposium, October 7-8, 2009, at Beurs van Berlage in Amsterdam. The program for Planet xMAP Europe 2009...

17 - Pluristem Therapeutics Has Been Selected to Present at The Israeli Presidential Conference 2009: Facing Tomorrow, Based on the Company’s Proprietary Technology and the Potential to Shape The Future of the Stem Cell Industry

HAIFA, Israel-(Business Wire)-September 29, 2009 - Pluristem Therapeutics Inc. (NasdaqCM: PSTI) (DAX: PJT) today announced it has been selected as one of the Israeli innovators in the stem cell field to present at The Israeli Presidential Conference 2009: Facing Tomorrow – Tomorrow's Industries...

18 - Vitae Receives $8 Million Payment from Boehringer Ingelheim for Achievement of 11beta-HSD-1 Program Milestone

FORT WASHINGTON, Pa.-(Business Wire)-September 29, 2009 - Vitae Pharmaceuticals, Inc., an integrated discovery and development company, today announced that it has earned an $8 million milestone payment from Boehringer Ingelheim for achievement of a performance milestone in their...

19 - Click Commerce to Automate Key Research Administration Processes for Lawrence Berkeley National Laboratory

BEAVERTON, Ore.-(Business Wire)-September 29, 2009 - Click Commerce announced today that Lawrence Berkeley National Laboratory (LBNL) will use Click Commerce’s eResearch Portal software to fully automate grants funding proposal creation and submissions, post-award grants management...

20 - Plexxikon Announces First Patient Dosed in First of Two Pivotal Trials of PLX4032 for Metastatic Melanoma

BERKELEY, Calif.-(Business Wire)-September 29, 2009 - Plexxikon Inc. announces that enrollment has been initiated and the first patient has been treated in the first of two pivotal trials of PLX4032 (RG7204) in patients with metastatic melanoma. PLX4032 is a novel, oral and highly selective drug...

21 - Sermo Panels Tap into Social Media Platform for On-Demand Physician Opinions

CAMBRIDGE, Mass.-(Business Wire)-September 29, 2009 - Sermo, the largest online community exclusively for physicians, today formally launched Sermo Panels™ - a new on-demand offering enabling businesses to engage with and gather insights from physicians in a private online workspace. Sermo Panels...

22 - Research and Markets: Hit and Lead Profiling: Identification and Optimization of Drug-Like Molecules

DUBLIN-(Business Wire)-September 29, 2009 - Research and Markets profiling are covered in separate parts. The ADME section covers the profiling of basic physicochemical parameters, such as solubility and permeability, as well as more complex traits, such as the likelihood of drug-drug interactions...

23 - SFC Fluidics, LLC Receives Funding from US Army for Development of Traumatic Brain Injury Diagnostic Device

FAYETTEVILLE, Ark.-(Business Wire)-September 29, 2009 - SFC Fluidics, LLC recently announced it has received a contract for approximately $5 million from the Congressionally Directed Medical Research Program for development of a handheld device for rapid diagnosis of traumatic brain injury (TBI...

24 - Research and Markets: This Essential Report on Technological Advances in Microscopy is Now Available

DUBLIN-(Business Wire)-September 29, 2009 - Research and Markets has announced the addition of Frost & Sullivan's new report "Technological Advances in Microscopy" to their offering. This Frost & Sullivan research service titled Technological Advances in Microscopy provides an overview of...

25 - Life Technologies Foundation Awards $1.7 Million in Grants to Advance Science

CARLSBAD, Calif.-(Business Wire)-September 29, 2009 - The Life Technologies Foundation, a non-profit arm of Life Technologies Corporation (NASDAQ: LIFE) dedicated to advancing science education and scientific discovery, has awarded approximately $1.7 million in new grants that include the creation...

26 - TruTouch Technologies Names Dr. Richard D. Gill as President and Chief Executive Officer

ALBUQUERQUE, N.M.-(Business Wire)-September 29, 2009 - TruTouch Technologies, a pioneer in non-invasive intoxication measurement systems, today named longtime industry executive Dr. Richard D. Gill as President and Chief Executive Officer. Dr. Gill joins TruTouch after nearly 30 years of strategic...

27 - Computable Genomix Announces Contest For Genomics Researchers

MEMPHIS, Tenn.-(Business Wire)-September 29, 2009 - Memphis-based Computable Genomix today announced it will launch a contest on Oct. 1, 2009, to coincide with the release of GeneIndexer, the company’s next-generation Web-based text-mining tool. Publish or Perish will award a $10,000 grant to each...

28 - IOCOM and Integrated Ocean Drilling Program Partner for Educational Video Conferencing Tutorials

CHICAGO-(Business Wire)-September 29, 2009 - IOCOM, a leading software provider for enterprise-class video conferencing and collaboration capabilities, today announced its ongoing partnership with the Integrated Ocean Drilling Program’s (IODP) Deep Earth Academy to offer educational video...

29 - Vivakor Announces Former General Electric Healthcare Division Executive Joins Its Board of Directors

CORALVILLE, Iowa-(Business Wire)-September 29, 2009 - Vivakor, Inc. (OTCBB: VIVK) today announced that John Gryga, former executive with General Electric’s Healthcare division and former Director of Operations for RadNet, has joined Vivakor’s Board of Directors. At RadNet, Mr. Gryga was...

30 - SAIC-Frederick and Roche Enter into a Research Collaboration on Technology Advancements for Cancer Gene Sequencing

MADISON, Wis.-(Business Wire)-September 29, 2009 - National Cancer Institute contractor SAIC-Frederick, Inc., a wholly owned subsidiary of Science Applications International Corporation (NYSE: SAI), and Roche Applied Science, a division of Roche Diagnostics Corporation (SWX:RO) (SWX:ROG) (Pink...

31 - Aurora Breast MRI of Sarasota and Clear Channel Radio, Partner for “Change for Change” Fundraising Event

SARASOTA, Fla.-(Business Wire)-September 29, 2009 - Aurora Breast MRI of Sarasota today announced it has partnered with Clear Channel Radio for a fundraising effort to benefit The Wellness Community of Southwest Florida. The fundraiser, titled “Change for Change,” will consist of a series of...

32 - Scarab Genomics Introduces ScarabXpress™ T7lac, a unique E. coli expression strain

MADISON, Wis.-(Business Wire)-September 29, 2009 - ScarabXpress is the latest strain in the multiple-deletion series (MDS) of Scarab Genomics Clean Genome® E. coli. Based on the MDS™42 strain, ScarabXpress T7lac contains a chromosomal copy of the T7 RNA polymerase gene expressed from a unique...

33 - Jova Solutions Announces Low-Cost CMOS Image Sensor Tester ISL-3200

SAN FRANCISCO-(Business Wire)-September 29, 2009 - Jova Solutions, a pioneer in low-cost, high-function automated testing solutions, today announced its next-generation image sensor tester, the ISL-3200. The ISL-3200 is a CMOS image sensor test and measurement system, which, for as little as $9,995...

34 - Dynavax Initiates Phase 3 Registration Trial in Chronic Kidney Disease Patients for HEPLISAVTM Hepatitis B Vaccine

BERKELEY, Calif.-(Business Wire)-September 29, 2009 - Dynavax Technologies Corporation (Nasdaq:DVAX) today announced the initiation of a Phase 3 registration trial for HEPLISAVTM hepatitis B vaccine in individuals with chronic kidney disease. A second registration trial, a Phase 3 lot-to-lot...

35 - National Archives and Footnote.com Announce New Digital Holocaust Collection

WASHINGTON & LINDON, Utah-(Business Wire)-September 29, 2009 - The National Archives and Records Administration (NARA) and Footnote.com (www.footnote.com) today announced the release of the internet's largest Interactive Holocaust Collection. For the first time ever, over one million...

36 - Hanford Pharmaceuticals Announces New Production Capabilities and Service Offerings

SYRACUSE, N.Y.-(Business Wire)-September 29, 2009 - On September 24, 2009, Hanford Pharmaceuticals (“Hanford” or the “Company”) completed the sale of its Cephalosporin manufacturing facility in Syracuse, NY, an asset that had been under-performing for quite some time. As part of the deal...

37 - At 2009 Technology Transfer Society Conference, IP Advocate Founder Dr. Renee Kaswan to Take Aim at Commercialization Barriers Faced by University Faculty Inventors

ATLANTA-(Business Wire)-September 29, 2009 - Speaking of the then-divided Berlin, former President Reagan famously admonished Soviet leader Gorbachev to “tear down this wall.” In a similar spirit, IP Advocate founder Dr. Renee Kaswan is calling on the university technology transfer system to...

38 - Precision BioSciences Announces U.S. Patent Office Reexamination of Cellectis Patents Involved in Litigation

RESEARCH TRIANGLE PARK, N.C.-(Business Wire)-September 29, 2009 - Precision BioSciences, Inc. today announced that the United States Patent and Trademark Office (PTO) has granted Precision’s requests for inter partes reexamination of U.S. Patent Nos. 6,610,545 (the ‘545 patent) and 7,309,605...

39 - Economy Not Key In Residents' Love For Where They Live

MIAMI-(Business Wire)-September 29, 2009 - A Gallup study of 26 U.S. communities has found that the worst economic crisis in decades is not a key factor in attracting and retaining residents. "While the pain from the recession is deep, other factors far outweigh economics when it comes to...

40 - Inc. Magazine Names InVivo Therapeutics CEO Frank Reynolds one of ‘America’s Most Innovative Entrepreneurs’

CAMBRIDGE, Mass.-(Business Wire)-September 28, 2009 - Frank Reynolds, InVivo Therapeutics President and CEO, has been identified as one of ‘‘America’s most innovative entrepreneurs’ in the October 2009 issue of Inc. Magazine. In the article entitled “The New and Improved You,” Inc...

41 - Impax Laboratories to Present at the JMP Securities Healthcare Focus Conference

HAYWARD, Calif.-(Business Wire)-September 28, 2009 - Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will present at the JMP Securities Healthcare Focus Conference on Monday, October 5th, at 12:30 p.m. Eastern time. The conference will be held at The New York Palace Hotel...

42 - The Tennessee Biotechnology Association (TBA) Announces New Board Members

NASHVILLE, Tenn.-(Business Wire)-September 28, 2009 - The Tennessee Biotechnology Association: Richard Magid, PhD is Vice President at the University of Tennessee Research Foundation (UTRF) at the UT Health Science Center (UTHSC), and manages the operations of the Memphis office. This office is...

43 - UCSF Orthopaedic Trauma Institute Selected for New Trauma Research Consortium

SAN FRANCISCO-(Business Wire)-September 28, 2009 - The Orthopaedic Trauma Institute (OTI) at the San Francisco General Hospital and Trauma Center and University of California, San Francisco has been chosen to serve as one of 12 core clinical centers in a newly established Extremity Trauma Clinical...

44 - DiscoveryBioMed, Inc. Awarded Phase 2 SBIR Grant by the NIH to Discover Hypertension and Cystic Fibrosis (CF) Drugs

BIRMINGHAM, Ala.-(Business Wire)-September 28, 2009 - DiscoveryBioMed, Inc. (DBM) today announced that it has been awarded a $750,000 Small Business Innovations Research (SBIR) Phase 2 grant by the National Institutes of Health (NIH) to continue the research into the discovery and development of...

45 - German Consulate & State of Hessen Life Science Networking Event: “Innovative Solutions to Challenges in Life Science in Germany,” New York, Tuesday 10/6/2009

NEW YORK-(Business Wire)-September 28, 2009 - German State of Hessen U.S. Office for Economic Development: German Life Science Speaker Panel and Networking Reception   Welcome & Introduction: Dr. Horst Freitag, Consul General   Speakers: Dr. Christian Garbe, Managing Director FIZ Frankfurt...

46 - Biomagnetics Diagnostics Receives a Financing Commitment up to $1 Million to Speed Development of Malaria Testing Technology

GENEVA-(Business Wire)-September 28, 2009 - Biomagnetics Diagnostics Corp., (PINK SHEETS:BMGP) a producer of revolutionary diagnostic systems and technology for malaria, tuberculosis, HIV and hepatitis testing today announced it has received a equity-based financing commitment up to $1 million...

47 - Ligand and GlaxoSmithKline Collaboration Identifies New Compound

SAN DIEGO-(Business Wire)-September 28, 2009 - Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) today announced that pursuant to an amendment to a March 2006 research agreement with GlaxoSmithKline (NYSE:GSK), GSK has agreed to accelerate the timing of a $500,000 payment to Ligand that would...

48 - RXi Pharmaceuticals to Webcast Investor Event on October 5, 2009

WORCESTER, Mass.-(Business Wire)-September 28, 2009 - RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it will webcast its Second Annual...

49 - Hythiam Announces First Peer-Reviewed Publication of Statistically Significant Results from Randomized, Double-Blind, Placebo-Controlled Study

LOS ANGELES-(Business Wire)-September 28, 2009 - Hythiam, Inc. (NASDAQ:HYTM) announced today that the results of a double-blind, placebo-controlled study on the impact of the medical component of the PROMETA® Treatment Program on alcohol dependent subjects was accepted and published in the...

50 - Merck & Co., Inc. Obtains Exclusive U.S. Marketing Rights for AFLURIA®, Seasonal Influenza Vaccine from CSL Biotherapies

WHITEHOUSE STATION, N.J.-(Business Wire)-September 28, 2009 - Merck & Co., Inc. announced today that the Company has entered into an exclusive agreement with CSL Biotherapies, a subsidiary of CSL Limited, to market and distribute AFLURIA® (Influenza Virus Vaccine), CSL's seasonal influenza...

51 - Ahura Scientific and QinetiQ North America Announce Development Partnership

WILMINGTON, Mass.-(Business Wire)-September 28, 2009 - Ahura Scientific, Inc., the leader in field-deployed analytical instruments for human health and public safety, today announced that it has formed a development partnership with the Technology Solutions Group of QinetiQ North America, a provider...

52 - TRADE NEWS: Agilent Technologies Introduces New Complex Proteomics Standard at HUPO 8th Annual World Congress

TORONTO-(Business Wire)-September 28, 2009 - Agilent Technologies Inc. (NYSE:A) today announced the new Agilent Complex Proteomics Standard, created to help researchers with protein biomarker discovery by validating mass-spectrometry-based workflows for protein identification. It is the most...

53 - PerkinElmer’s Exclusive Hyphenated Scientific Instrumentation Allows Simultaneous Testing for the Drug and Plastic Industries

SHELTON, Conn.-(Business Wire)-September 28, 2009 - PerkinElmer, Inc., a global leader focused on the health and safety of people and the environment, has emerged as a leader in hyphenated scientific instrumentation with the launch of its exclusive Differential Scanning Calorimetry (DSC)-Raman...

54 - Helicos Announces System Sale to Correlagen Diagnostics

CAMBRIDGE, Mass.-(Business Wire)-September 28, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) today announced the sale of a system and a scientific collaboration with Correlagen Diagnostics Inc., a leading provider of genetic tests for disease diagnosis. “We are very excited to have...

55 - Selcia Launches New Discovery Division with Powerful Fragment Screening Platform and Unveil Company Re-brand

ONGAR, Essex, UK-(Business Wire)-September 28, 2009 - Selcia Ltd, a worldwide industry leading C-14 custom radiolabelling provider and drug discovery company this week launched their new Fragment Screening Platform and unveiled their new brand as part of ambitious international expansion plans...

56 - Life Technologies and febit Team to Offer New Solution for Targeted Re-sequencing in Large-scale Genomic Studies

CARLSBAD, Calif. & HEIDELBERG, Germany-(Business Wire)-September 28, 2009 - febit holding GmbH and Life Technologies Corporation (NASDAQ: LIFE) today announced that they have entered into a strategic co-marketing agreement to provide a new, scalable solution for researchers conducting targeted...

57 - Petroleum Technology Alliance Canada (PTAC) is pleased to announce the release of Phase One study entitled– “Alternative Energy Solutions to Reduce Dependency of Natural Gas Consumption for Oil Sands Development (Phase One)”

CALGARY-(Business Wire)-September 25, 2009 - Petroleum Technology Alliance Canada (PTAC) is pleased to announce the release of the report entitled Alternative Energy Solutions to Reduce Dependency of Natural Gas Consumption for Oil Sands Development (Phase One)”. Nuclear power is capable of making...

58 - SpaceX’s DragonEye Navigation Sensor Successfully Demonstrated on Space Shuttle

HAWTHORNE, Calif.-(Business Wire)-September 25, 2009 - Space Exploration Technologies (SpaceX) announces the successful demonstration of a proximity sensor, called DragonEye, on NASA’s STS-127 shuttle mission. DragonEye launched aboard the Space Shuttle Endeavour on July 15th, 2009, and was tested...

59 - Accelr8 and Becton Dickinson Conclude Technical Development Project

DENVER-(Business Wire)-September 25, 2009 - Accelr8 Technology Corporation (NYSE Amex: AXK) announced today that it has concluded a technical development project with Becton, Dickinson and Company (“BD”) (NYSE: BDX). Accelr8’s technology met formal testing requirements for identification of...

60 - Research and Markets: Top 10 Companies in the US Life Sciences Industry: IT Spending Predictor 2009 Out Now

DUBLIN-(Business Wire)-September 25, 2009 - Research and Markets has announced the addition of the "Top 10 Companies in the US Life Sciences Industry: IT Spending Predictor 2009" report to their offering. This databook provides insight into the top 10 companies in the US life sciences industry in...

61 - RXi Pharmaceuticals Obtains Direct Ownership of Previously Licensed RNAi Delivery Intellectual Property

WORCESTER, Mass.-(Business Wire)-September 25, 2009 - RXi Pharmaceuticals Corporation (Nasdaq: RXII), a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that it has recently acquired direct...

62 - EnzymeRx Announces Its IND for Uricase-PEG 20 Becomes Effective

PARAMUS, N.J.-(Business Wire)-September 25, 2009 - EnzymeRx, LLC (www.enzymerx.com), a clinical-stage biotechnology company, today announced that its Investigational New Drug (IND) application for Uricase-PEG 20, filed with the U.S. Food and Drug Administration (FDA) last month, has become...

63 - Altor BioScience Awarded $3 MM SBIR Bridge Grant by NCI to Advance Clinical Trials for its Targeted Cancer Therapeutic ALT-801

MIRAMAR, Fla.-(Business Wire)-September 25, 2009 - Altor BioScience Corporation announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase II Bridge Grant by the National Cancer Institute (NCI). The award of $3 MM over three years will help Altor further its...

64 - Allos Therapeutics’ FOLOTYN™ First and Only FDA-Approved Therapy for Relapsed or Refractory Peripheral T-cell Lymphoma

WESTMINSTER, Colo.-(Business Wire)-September 25, 2009 - Allos Therapeutics, Inc. (Nasdaq:ALTH) today announced that last night the U.S. Food and Drug Administration (FDA) granted accelerated approval for FOLOTYNTM (pralatrexate injection) for use as a single agent for the treatment of patients...

65 - Advanced Visual Systems Begins Trading on OTC

WALTHAM, Mass.-(Business Wire)-September 25, 2009 - Advanced Visual Systems Inc. (www.avs.com), an innovator of data visualization software and solutions, began trading its common stock on the OTC Pink Sheets (Pink Sheets: AVSC) on September 15, 2009. The company, founded in 1991, develops and...

66 - Tryton Medical, Inc. Broadcasts Successful Live Case Using Company’s Side-Branch Stent™ to Definitively Treat Bifurcation Lesions at TCT 2009

DURHAM, N.C. & SAN FRANCISCO-(Business Wire)-September 24, 2009 - Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced today the transmission of a live satellite feed of a clinical case performed in the United Kingdom to an...

67 - Arizona Residents Greg and Lauren Glassman Recognized for Their Support in Fighting Cancer

SANTA MONICA, Calif.-(Business Wire)-September 24, 2009 - Greg and Lauren Glassman, founders of CrossFit, Inc., are providing crucial funding for the battle against prostate cancer. In acknowledgement of CrossFit’s annual Fight Gone Bad event that has raised more than $1 million since 2006, the...

68 - Inhibitex Regains Compliance with NASDAQ Listing Requirements

ATLANTA-(Business Wire)-September 24, 2009 - Inhibitex, Inc. (Nasdaq: INHX) (the “Company”), a biopharmaceutical company focused on developing products to treat serious infectious diseases, announced today that it has received notice from The NASDAQ Stock Market ("Nasdaq") stating that, as the...

69 - Filmetrics Introduces SampleCam for Live Online Support of Film Thickness and Thin-Film Measurement Applications

SAN DIEGO-(Business Wire)-September 24, 2009 - Filmetrics has announced the release of its SampleCam video accessory. The SampleCam enables an important advance in film thickness measurement by significantly increasing data available remotely to support personnel. It attaches easily to the sample...

70 - TRADE NEWS: Agilent Technologies, Shanghai Institute of Biological Sciences and Chinese Academy of Sciences Open Center for Systems Biology

SANTA CLARA, Calif. & SHANGHAI-(Business Wire)-September 24, 2009 - Agilent Technologies Inc. (NYSE:A) today announced the opening of the Shanghai Institute of Biological Sciences (SIBS)-Agilent Center for Systems Biology in Shanghai, China. The center will feature multiple technology...

71 - QuantaSol Adopts Dilute Nitrides to Boost Absorption and Solar Efficiency

KINGSTON-UPON-THAMES, England-(Business Wire)-September 24, 2009 - QuantaSol Ltd, an independent designer and manufacturer of strain-balanced quantum-well solar cells has exclusively licensed advanced materials growth technology from the University of Houston to make its manufacturing process...

72 - Boston Scientific Founder John Abele Joins Nanobiosym Global Advisory Board

BOSTON-(Business Wire)-September 24, 2009 - Nanobiosym® today announced that John Abele, Cofounder and former Co-Chairman of the multibillion-dollar global medical device company, Boston Scientific, has joined the Nanobiosym Global Advisory Board. Over the past 30 years, Mr. Abele led the...

73 - Simbiote’s ReCES® Application Simplifies Participation in Pharmaceutical-Sponsored Research

OLIVE BRANCH, Miss.-(Business Wire)-September 24, 2009 - Simbiote Development, which develops software solutions to quantifiably improve quality of care, support risk management and strengthen revenue opportunities in physician practices, today introduced its Research Candidate Evaluation System...

74 - RegeneRx Biopharmaceuticals to Present Several Papers at Second International Symposium on Thymosins in Health and Disease

BETHESDA, Md.-(Business Wire)-September 24, 2009 - REGENERX BIOPHARMACEUTICALS, INC. (NYSE Amex:RGN) (www.regenerx.com) announced today that it will participate in the Second International Symposium on Thymosins in Health and Disease. This conference will take place from September 30, through...

75 - Health Discovery Corporation’s Dr. Stephen Barnhill Tells Participants at London Conference That Biomarkers Patented by His Company Promise to Revolutionize The Field of Molecular Diagnostics

SAVANNAH, Ga.-(Business Wire)-September 24, 2009 - Dr. Stephen Barnhill, Chairman and CEO, Health Discovery Corporation (OTCBB: HDVY) (“HDC”), a molecular diagnostics company, spoke at the “Biomarkers in Clinical Trials” Conference taking place in London, September 23-24, 2009. The...

76 - Inovio Biomedical CEO Addresses MIT’s Emerging Technologies Conference

SAN DIEGO-(Business Wire)-September 24, 2009 - Inovio Biomedical Corporation (NYSE Amex: INO), a leader in DNA vaccine design, development and delivery, announced today that Dr. J. Joseph Kim, Inovio’s CEO, presented keynote remarks at MIT’s Emerging Technologies Conference hosted by the...

77 - Genzyme’s Campath Meets Primary Endpoint in Phase 3 Combination Therapy Trial for Chronic Lymphocytic Leukemia

CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Genzyme Corporation (Nasdaq: GENZ) announced today that its randomized Phase 3 clinical trial investigating Campath® (alemtuzumab) in combination with Fludara® (fludarabine phosphate) in relapsed or refractory chronic lymphocytic leukemia (CLL...

78 - Pubget Activates 100th Research Institution, Accelerates Journal Content Consumption Across Publishers

PROVIDENCE, R.I.-(Business Wire)-September 24, 2009 - Pubget, the life science search engine empowering full-text journal access, today activates its 100th research institution. This brings Pubget’s capabilities to an estimated base of 500,000 research scientists and clinicians worldwide. “I’m...

79 - 17th Annual BioPartnering Europe™ and BioPartnering China™ Presents Innovative and Informative Program, Addressing Latest Trends Affecting the Biotech Industry Today

LONDON-(Business Wire)-September 24, 2009 - Technology Vision Group (TVG) is pleased to announce details of the program for the 17th Annual BioPartnering Europe (BPE) and BioPartnering China (BPC) conference in London from 11-14 October 2009, providing four days of networking in one location...

80 - Alkermes Announces Amylin and Lilly Will Present More than 20 Studies for Exenatide at EASD 2009

SAN DIEGO & INDIANAPOLIS & CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN), Eli Lilly and Company (NYSE: LLY) and Alkermes, Inc. (Nasdaq: ALKS) will unveil data from more than 20 studies at the 45th Annual Meeting of the European...

81 - Global Prostate Cancer Research Meeting Opens

SANTA MONICA, Calif.-(Business Wire)-September 24, 2009 - Nearly of 300 of the world’s leading researchers focused on the problem of prostate cancer will begin a three-day meeting today to discuss the latest scientific data and breakthroughs in prostate cancer. The meeting, held in Incline Village...

82 - Research and Markets: Biohydrometallurgy 2009

DUBLIN-(Business Wire)-September 24, 2009 - Research and Markets , 13-17 September 2009, Bariloche, Argentina. The main focus of this collection of peer-reviewed articles is three different aspects of biohydrometallurgy: this is the field of microbial ecology which is the key to answering central...

83 - Research and Markets: Demand-Driven Forecasting: a Structured Approach to Forecasting

DUBLIN-(Business Wire)-September 24, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Demand-Driven Forecasting: A Structured Approach to Forecasting" to their offering. This is a practitioner based book that provides readers with real proven processes...

84 - Helicos Announces First-Ever Direct Sequencing of Single Molecules of RNA

CAMBRIDGE, Mass.-(Business Wire)-September 24, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS), a life science company focused on innovative genetic analysis technologies, today announced the publication of a landmark study in which Helicos’ True Single Molecule Sequencing (tSMS...

85 - Research and Markets: Microfluidics 2009

DUBLIN-(Business Wire)-September 24, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Microfluidics 2009" to their offering. The recent on-going development of micro technologies allows designing complex microsystems devoted to transport, dosing...

86 - Research and Markets: Electromagnetic Simulation Techniques Based on the FDTD Method

DUBLIN-(Business Wire)-September 24, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Electromagnetic Simulation Techniques Based on the FDTD Method" to their offering. Bridges the gap between FDTD theory and the implementation of practical simulation...

87 - The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine

-(Business Wire)-September 24, 2009 - MEDIA ADVISORY:   WHAT:   International Symposium “Toward a Vaccine that Elicits Broadly Neutralizing Antibodies against HIV.” More than 70 leading HIV/AIDS vaccine researchers will gather to discuss recent scientific advances in the quest to develop an...

88 - Teva Provides Update on Generic Evista® Litigation

JERUSALEM-(Business Wire)-September 24, 2009 - Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U.S. District Court for the Southern District of Indiana has issued a decision invalidating two patents listed in the FDA’s Orange Book for Eli Lilly’s Evista...

89 - IAVI Statement on Results of Phase III ALVAC-AIDSVAX Trial in Thailand

NEW YORK-(Business Wire)-September 24, 2009 - The International AIDS Vaccine Initiative (IAVI) greeted with excitement today’s announcement by the U.S. Military HIV Research Program and the Thai Ministry of Public Health that, according to an initial analysis, a prime-boost combination of two AIDS...

90 - Results of ADAGIO Study with AZILECT® in Parkinson’s Disease Published in New England Journal of Medicine

JERUSALEM-(Business Wire)-September 23, 2009 - Results from the ADAGIO trial, published online today in The New England Journal of Medicine, demonstrated that Parkinson’s disease patients receiving AZILECT® (rasagiline) 1mg/day at the start of the study (early-start group) experienced superior...

91 - FDA Advisory Committee Hears Presentations and Public Comment on EXALGO Extended-Release Tablets

CAMBRIDGE, Mass. & VANCOUVER-(Business Wire)-September 23, 2009 - CombinatoRx, Incorporated (NASDAQ: CRXX) and Neuromed Pharmaceuticals, Inc., a privately-held biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) in a joint meeting of its Anesthetics and...

92 - FAME Trial Two-Year Follow-Up Results Demonstrate Continued Reduction in Risk of Death or Heart Attack When Physicians Use St. Jude Medical Fractional Flow Reserve Technology Prior to Implanting Coronary Stents

ST. PAUL, Minn.-(Business Wire)-September 23, 2009 - St. Jude Medical, Inc. (NYSE:STJ) today announced that the two-year results from the landmark FAME (Fractional Flow Reserve (FFR) vs. Angiography in Multivessel Evaluation) trial demonstrated the durability of the improved outcomes noted at...

93 - Ad-ology Research Home Maintenance Survey: Nearly 30% Higher-Income Consumers are Influenced by Social Media

WESTERVILLE, Ohio-(Business Wire)-September 23, 2009 - Nearly 30% of higher-income consumers said social media influenced their choice of home maintenance or repair services, a markedly higher percentage than other income groups. The Ad-ology Research study also found this group had notably high...

94 - RainDance Expands Sequence Enrichment Solution Capabilities with 20,000 Amplicon Library and Whole Genome Amplification Protocol

PROVIDENCE, R.I.-(Business Wire)-September 23, 2009 - RainDance Technologies, Inc., a leading provider of innovative microdroplet-based solutions for health and human disease research, announced today it has expanded the capabilities of its Sequence Enrichment Solution to enable the resequencing...

95 - Cal/OSHA Recognizes IBM Research-Almaden for Workplace Safety Achievements

SAN JOSE, Calif.-(Business Wire)-September 23, 2009 - The Department of Industrial Relations’ Division of Occupational Safety & Health (DIR/DOSH) today awarded its 71st Voluntary Protection Program (VPP) STAR Flag to IBM Research - Almaden in the Silicon Valley. IBM Research - Almaden performs...

96 - LifeSensors, Inc. Obtains Worldwide, Exclusive License to High Affinity “Ubiquitin Traps”

MALVERN, Pa.-(Business Wire)-September 23, 2009 - LifeSensors, Inc., a biotechnology company specializing in protein expression technologies and ubiquitin pathway research tools, announced today their worldwide, exclusive license for high affinity ubiquitin traps. These new research tools, developed...

97 - First-Ever Controlled Pharmacological Study of ADHD in College Students Launched

BETHLEHEM, Pa.-(Business Wire)-September 23, 2009 - In an effort to help one of the most under studied groups of sufferers of attention deficit hyperactivity disorder (ADHD), researchers at University of Rhode Island and Lehigh University have kicked off the first-ever controlled pharmacological...

98 - Bio-Computing a Major Focus of 22nd Annual SC Conference

PORTLAND, Ore.-(Business Wire)-September 23, 2009 - SC09, the 22nd annual supercomputing conference, recognized as the premier international conference on high performance computing (HPC), networking, storage and analysis, will offer presentations, seminars and panels featuring a world-class...

99 - Bio-Matrix Scientific Group and Therinject LLC Begin Development of Tumor Banking Facility in Conjunction with Cancer Therapeutic Vaccine

SAN DIEGO-(Business Wire)-September 23, 2009 - Bio-Matrix Scientific Group, Inc. (OTCBB: BMSN) announced today that the Company and Therinject LLC have begun development of a tumor banking facility. Tumor banking will allow storage and ease of sourcing for tumor cells to be utilized in cancer...

100 - Data Presented from Two Phase 3 ERBITUX® Studies in First-Line Metastatic Colorectal Cancer Patients at Joint 15th European Cancer Organisation and 34th European Society for Medical Oncology Multidisciplinary Congress

BERLIN-(Business Wire)-September 23, 2009 - According to a recent retrospective analysis of the pivotal Phase 3 CRYSTAL study, ERBITUX® (cetuximab), when added to FOLFIRI, was shown to increase median overall survival to 19.9 months in an intent-to-treat (ITT) population of first-line metastatic...

101 - Lux Biosciences Reports Phase 1 Safety Results and Open Label Efficacy Results for LX214, a Potential Best-in-Class Treatment for Dry Eye

JERSEY CITY, N.J.-(Business Wire)-September 23, 2009 - Lux Biosciences, Inc. a privately held biotechnology company focused on the treatment of ophthalmic diseases, today announced results from a Phase 1 human safety and an open-label pilot efficacy study of the company’s potential best-in-class...

102 - AuthenTec to Demonstrate New Smart Sensor Features and Products at CTIA WIRELESS I.T. & Entertainment

MELBOURNE, Fla.-(Business Wire)-September 23, 2009 - AuthenTec (NASDAQ:AUTH), the world’s leading provider of smart sensor based solutions, announced that it will demonstrate its newest mobile products and software, and will highlight new commercially released phones that incorporate its...

103 - Philips and Bruker BioSpin Sign Memorandum of Understanding to Bring New Imaging Technology to the Preclinical Market

MONTREAL-(Business Wire)-September 23, 2009 - At the 2009 World Molecular Imaging Congress (WMIC) in Montreal, Royal Philips Electronics (NYSE: PHG, AEX: PHI) and Bruker BioSpin, a division of Bruker Corporation (NASDAQ: BRKR), today announced that they have signed a memorandum of understanding...

104 - Philips and Celsion Advance Development of ThermoDox® and MR-Guided HIFU

ANDOVER, Mass. & COLUMBIA, Md.-(Business Wire)-September 23, 2009 - Royal Philips Electronics (NYSE: PHG; AEX: PHI) and Celsion Corporation (NASDAQ: CLSN) today announced that their joint research program to evaluate ThermoDox® in combination with MR-HIFU (Magnetic Resonance guided High...

105 - CombinatoRx Stock Trading Halted Today; FDA Advisory Committees Meet to Discuss Exalgo

CAMBRIDGE, Mass. & VANCOUVER-(Business Wire)-September 23, 2009 - CombinatoRx, Incorporated (NASDAQ: CRXX) announced that NASDAQ has halted trading in the Company’s common stock today. The U.S. Food and Drug Administration’s (FDA) Anesthetics and Life Support Advisory Committee and its...

106 - Pluristem Therapeutics Doses First Patient in U.S. With Placenta-Derived Stem Cell Product PLX-PAD in a Phase I Clinical Trial for Treatment of Peripheral Artery Disease

HAIFA, Israel-(Business Wire)-September 23, 2009 - Pluristem Therapeutics Inc. (NasdaqCM: PSTI; DAX: PJT) today announced the dosing of the first patient in the U.S. with its placenta-derived stem cell product, PLX-PAD, the Company’s leading candidate, in a Phase I clinical trial for the treatment...

107 - Research and Markets: Controlled/Living Polymerizations: Methods and Materials - Now Available

DUBLIN-(Business Wire)-September 23, 2009 - Research and Markets n Linear Multiblock Copolymers ABC Triblock Terpolymers Synthesis of ABCA Tetra- and ABCBA Pentablock Terpolymers Synthesis of ABCD Quaterpolymers Applications MORPHOLOGIES IN BLOCK COPOLYMERS Block Copolymers in Bulk State Block...

108 - Labcyte Signs Bioscreen Instruments as Exclusive Distributor in India

SUNNYVALE, Calif. & CHENNAI, India-(Business Wire)-September 23, 2009 - Labcyte, the developer of acoustic liquid transfer, with systems in all top 10 pharmaceutical companies, today announced the selection of Bioscreen Instruments Pvt. Ltd. as its exclusive distributor in India. “Bioscreen is...

109 - BioTime, Inc. to Form Asian Subsidiary

BEIJING & ALAMEDA, Calif.-(Business Wire)-September 23, 2009 - BioTime, Inc. (OTCBB:BTIM) announced today that it will organize a new subsidiary, BioTime Asia, Limited, for the purpose of clinically developing and marketing therapeutic stem cell products in the People’s Republic of China...

110 - AHF’s Blair Underwood HIV/AIDS Clinic to Open in DC Thursday Sept. 24th

WASHINGTON-(Business Wire)-September 23, 2009 - AIDS Healthcare Foundation (AHF), the US’ largest non-profit HIV/AIDS healthcare provider, which provides medical care and/or services to more than 100,000 individuals in 21 countries worldwide, is honored to announce the September 24th grand opening...

111 - Miley Cyrus, Demi Lovato and Jesse McCartney to Perform at Second Annual Concert for Hope Presented by Staples, Inc., October 25 at Nokia Theatre L.A. LIVE

LOS ANGELES-(Business Wire)-September 22, 2009 - Disney Music Group artists Miley Cyrus, Demi Lovato and Jesse McCartney will hit all the right notes in the fight against cancer when they take the stage at the second annual Concert for Hope presented by Staples, Inc. on Sunday, October 25, it was...

112 - Susan G. Komen for the Cure® Founder Nancy G. Brinker Warns of Coming Global Cancer Crisis; Calls on World Leaders at United Nations to “Include Cancer” on Health Agendas

NEW YORK-(Business Wire)-September 22, 2009 - The leader of the global breast cancer movement today warned of a coming wave of cancer deaths and told global health ministers to be “fearless and united” in addressing the growing cancer crisis, particularly in developing countries. “Cancer takes...

113 - Environmental Leadership of Public Gardens to Take the Global Stage at the Upcoming G-20 Summit

KENNETT SQUARE, Pa.-(Business Wire)-September 22, 2009 - As testament to the important role that America’s public gardens play in promoting environmental stewardship and awareness, plant and water conservation, and education in communities nationwide, Phipps Conservatory and Botanical Gardens, a...

114 - BioSante Pharmaceuticals and Cell Genesys Announce Final Exchange Ratio for Merger

LINCOLNSHIRE, Ill. & SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 22, 2009 - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that they have determined the final exchange ratio as 0.1828 in connection with the previously announced...

115 - Axion Announces Official Public Unveiling of World’s First Thermoplastic Bridges Capable of Supporting Over 70 Tons

BASKING RIDGE, N.J.-(Business Wire)-September 22, 2009 - Axion International Holdings, Inc. (OTCBB:AXIH), a next-generation technology innovator utilizing recycled plastic for high load industrial products, today announces the official public unveiling of the high-load thermoplastic bridges designed...

116 - Governor Christine Gregoire Officially Dedicates New AMRI Research Facility in Bothell, Washington

BOTHELL, Wash.-(Business Wire)-September 22, 2009 - AMRI (NASDAQ:AMRI) executives were joined by Governor Christine Gregoire in dedicating the company’s new research & development facility located in Bothell, WA. The company leased 44,000 square feet at 22215 26th Avenue SE with an option on...

117 - Top 20 Pharma Firms to Hunt for Deals at BIO-Europe 2009

ZURICH & VIENNA-(Business Wire)-September 22, 2009 - In order to seek out new partnering opportunities, the top 20 big pharma companies will be in attendance on November 2–4 in Vienna, Austria for BIO-Europe 2009, the largest dedicated partnering conference in Europe. Teams of scouts from...

118 - Sept. 15 House of Representatives Hearing on Space Flight Includes Misconceptions; Industry Group Offers Clarity

WASHINGTON-(Business Wire)-September 22, 2009 - Next Step in Space, a coalition of businesses, organizations, and people working toward ensuring the future of human spaceflight in the United States, today issued a white paper titled “Acquiring U.S. Commercial ISS Crew and Cargo Services Creates...

119 - Bio-Path Holdings, Inc. Announces Plans to Develop Liposome Tumor Targeting Technology Licensed from The University of Texas M. D. Anderson Cancer Center

HOUSTON-(Business Wire)-September 22, 2009 - Bio-Path Holdings, Inc. (OTCBB: BPTH), a publicly traded biotechnology company with drug development operations in Houston, Texas, announced today the Company has executed an exclusive license with The University of Texas M. D. Anderson Cancer Center to...

120 - Research and Markets: Chromatography: Concepts and Contrasts, 2nd Edition Discusses All the Different Types of Chromatography Under One Cover

DUBLIN-(Business Wire)-September 22, 2009 - Research and Markets . For more information visit http://www.researchandmarkets.com/research/41b2b5/chromatography_co.

121 - United BioSource Consolidates Leadership in Pharmaceutical Risk Management

BETHESDA, Md.-(Business Wire)-September 22, 2009 - United BioSource Corporation (UBC) today announced the acquisition of Gigamoto Technology Partners, Inc. (Gigamoto), a Pennsylvania-based software development company providing leading-edge technology solutions in support of drug safety and risk...

122 - Raydiance Smart LightTM Technology to Power Norman Noble’s Noble UltraLightTM

PETALUMA, Calif.-(Business Wire)-September 22, 2009 - Raydiance Corporation, developer of the world’s first commercial-grade ultrafast laser, announced today that its Smart LightTM ultrafast platform will provide the core technology for an advanced laser machining process, Noble UltraLightTM, to...

123 - PacifiCord Secures Sterile Cord Blood Collection Bag

IRVINE, Calif.-(Business Wire)-September 22, 2009 - Dedicated to serving the private cord blood banking needs of Southern California, PacifiCord (www.pacificord.com) today announced it has secured Pall Corporation’s sterile cord blood collection bag. Since April 2006, this industry-best sterile...

124 - TRADE NEWS: Agilent Technologies, Life Technologies Co-Market Target-Enrichment System for Next-Generation Sequencing

SANTA CLARA, Calif. & CARLSBAD, Calif.-(Business Wire)-September 22, 2009 - Agilent Technologies Inc. (NYSE:A) and Applied Biosystems, part of Life Technologies Corp. (NASDAQ:LIFE), today introduced the Agilent SureSelect Target Enrichment System, which is optimized for the SOLiD™ System, a...

125 - PHOTON Consulting Announces the Release of Solar Annual 2009: Total Eclipse.

BOSTON-(Business Wire)-September 22, 2009 - PHOTON Consulting, the leading research and management consulting firm focused on the global solar power sector announced this morning that it has released Solar Annual 2009: Total Eclipse, the latest installment of its highly regarded Solar Annual...

126 - National Algae Association Awards Top Honor to Cyclone Power Technologies

POMPANO BEACH, Fla.-(Business Wire)-September 22, 2009 - Cyclone Power Technologies (Pink Sheets:CYPW) received the “Algaepreneur 2009 Award” at the National Algae Association Conference, held last week in Houston, TX. The Algaepreneur Award honors companies and individuals who make important...

127 - PHT’s LogPad ePRO System used by Jazz Pharmaceuticals

BOSTON-(Business Wire)-September 22, 2009 - PHT Corporation announced that Jazz Pharmaceuticals (Nasdaq: JAZZ) has used PHT’s LogPad™ System to collect electronic patient reported outcomes (ePRO) in its recently completed clinical trial. Jazz Pharmaceuticals’ recent project builds on the...

128 - Safeguard Scientifics Announces Sale of 2.4 Million Additional Clarient Shares Pursuant to Overallotment Option

WAYNE, Pa.-(Business Wire)-September 22, 2009 - Safeguard Scientifics, Inc. (NYSE:SFE), a holding company that builds value in growth-stage life sciences and technology companies, today announced that it has sold an additional 2.4 million shares of its position in Clarient, Inc. (Nasdaq: CLRT...

129 - StemCells, Inc. Announces Initiatives to Advance Cell-Based Technologies for Pharmaceutical Industry and Research Applications

PALO ALTO, Calif.-(Business Wire)-September 22, 2009 - StemCells, Inc. (NASDAQ:STEM) today announced organizational initiatives focused on growing its specialty SC Proven® cell culture product business and advancing the development and commercialization of its central nervous system (CNS...

130 - Research and Markets: Bayesian Networks: an Introduction

DUBLIN-(Business Wire)-September 22, 2009 - Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Bayesian Networks: An Introduction" to their offering. A self-contained introduction to the theory and applications of Bayesian Networks Bayesian networks are a...

131 - Modular Genetics, Inc. to Present at the 18th Annual CBB/IBA Joint Conference on Biocatalysis and Bioprocessing on Tuesday, October 20, 2009.

CAMBRIDGE, Mass.-(Business Wire)-September 22, 2009 - Modular Genetics, Inc. (Modular) has announced today that it has been invited to present at the 18th Annual CBB/IBA Joint Conference on Biocatalysis and Bioprocessing 441-6000.

132 - Research and Markets: Electrochemical Remediation Technologies for Polluted Soils, Sediments and Groundwater

DUBLIN-(Business Wire)-September 22, 2009 - Research and Markets . INDEX. For more information visit http://www.researchandmarkets.com/research/8c2b62/electrochemical_re

133 - Helicos Presents at Cold Spring Harbor Laboratories Personal Genomes and CHI Next Generation Sequencing Meetings

CAMBRIDGE, Mass.-(Business Wire)-September 22, 2009 - Helicos BioSciences Corporation (NASDAQ: HLCS) provided updates on recent scientific findings and progress on Helicos’s technology initiatives. Speaking at the Personal Genomes conference in Cold Spring Harbor, NY, and the CHI Next Generation...

134 - Celera and Medco Enter Research Collaboration to Evaluate Effect of KIF6 Testing on Compliance with Statin Therapy in Patients with Cardiovascular Disease

ALAMEDA, Calif. & FRANKLIN LAKES, N.J.-(Business Wire)-September 22, 2009 - Celera Corporation (NASDAQ:CRA) and Medco Health Solutions, Inc. (NYSE:MHS), today announced that they have entered into a research collaboration to evaluate whether testing for a gene variant called KIF6 increases...

135 - Survival Benefit Maintained in Long Term Follow-up of IES with Pfizer’s AROMASIN® (Exemestane Tablets)

BERLIN-(Business Wire)-September 22, 2009 - Pfizer Inc today announced new, longer-term data from the Intergroup Exemestane Study (IES) showing that women who switched to AROMASIN® (exemestane tablets) after taking tamoxifen for two to three years experienced a significant reduction (18%) in the...

136 - Dynavax Announces HEPLISAVTM Data to Be Presented at IDSA Medical Conference

BERKELEY, Calif.-(Business Wire)-September 22, 2009 - Dynavax Technologies Corporation (Nasdaq:DVAX) today announced that an abstract with chronic kidney disease patient data for HEPLISAVTM, an investigational adult hepatitis B vaccine, will be presented at the 47th Annual Meeting of the...

137 - OriginOil Execs Unveil New Algae Productivity Model at National Algae Association’s Quarterly Conference

LOS ANGELES-(Business Wire)-September 22, 2009 - OriginOil, Inc. (OOIL), the developer of a breakthrough technology to transform algae, the most promising source of renewable oil, into a true competitor to petroleum, announced that the National Algae Association's (NAA) quarterly conference...

138 - Total, GDF SUEZ, and Photovoltech Join IMEC’s Silicon Solar Cell Research Program

LEUVEN, Belgium-(Business Wire)-September 22, 2009 - The two major energy companies Total and GDF SUEZ and their common solar cells manufacturing subsidiary Photovoltech join the IMEC industrial affiliation program (IIAP) on next generations of crystalline silicon solar cells. The multi-partner...

139 - Pfizer and Wyeth to Divest Certain Animal Health Assets to Boehringer Ingelheim

NEW YORK & MADISON, N.J.-(Business Wire)-September 21, 2009 - Pfizer Inc (NYSE: PFE) and Wyeth (NYSE: WYE) today announced that they have entered into an agreement with Boehringer Ingelheim to divest certain animal health assets in connection with the regulatory approval process associated...

140 - Burnham Appoints Michael R. Jackson, Ph.D., Vice President for Drug Discovery & Development

LA JOLLA, Calif.-(Business Wire)-September 21, 2009 - Burnham Institute for Medical Research (Burnham) has appointed Michael R. Jackson, Ph.D., to the newly created position of Vice President for Drug Discovery and Development. In this role, Dr. Jackson will oversee the chemical biology and drug...

141 - Early Bird Registration Deadline Extended for California Healthcare Policy Forum

LA JOLLA, Calif.-(Business Wire)-September 21, 2009 - CHI-California Healthcare Institute announced today it has extended its early bird registration deadline for the 2009 California Healthcare Policy Forum to Oct. 2. The forum, hosted by CHI and supported by Gilead Sciences, Sanofi-Aventis and...

142 - Mentor Capital, Inc. Completes 2nd Year Audit for OTCBB Move; Reporting $0.16 Per Share in Basic Earnings

SAN DIEGO-(Business Wire)-September 21, 2009 - Mentor Capital, Inc. (Pink Sheets:MNTR) completed its FY 2008 audit in preparation for filing a self-registration statement with the SEC and applying to move from the Pink Sheets to begin being quoted on the Over-the-Counter Bulletin Board system. The...

143 - Bio Nebraska Partners with Nebraska EPSCoR and University of Nebraska on 5th Annual Research and Innovation Conference in Omaha

OMAHA, Neb.-(Business Wire)-September 21, 2009 - Bio Nebraska Life Sciences Association, Nebraska EPSCoR and the University of Nebraska will host the 5th Annual Research and Innovation Conference on Tuesday, September 29, 2009 at the Qwest Center in Omaha. Registration begins at 7:30 a.m., and the...

144 - Cleveland FES Center Restores Movement to Individuals with Neuromuscular Disabilities Using MathWorks Tools

NATICK, Mass.-(Business Wire)-September 21, 2009 - The MathWorks today announced that the Cleveland FES Center, using tools for Model-Based Design, has developed research technology that more quickly restores movement to individuals with neuromuscular disabilities. Adopting Model-Based Design...

145 - BioForward Announces Winners of Biotechnology Vision Summit’s Emerging Company Showcase

MADISON, Wis.-(Business Wire)-September 21, 2009 - Six Wisconsin biotechnology companies have been selected the winners of the first Emerging Company Showcase. The showcase is part of the Biotechnology Vision Summit 2009, being held on Wednesday, Oct. 7, at the Madison Marriott West in Madison, Wis...

146 - Medtronic’s Resolute® Drug-Eluting Stent Maintains Strong, Sustained Efficacy and Safety in Long-Term Follow-up

SAN FRANCISCO-(Business Wire)-September 21, 2009 - New clinical data released today at a major meeting of interventional cardiologists show strong and sustained efficacy and safety of the Resolute® Zotarolimus-Eluting Coronary Stent from Medtronic, Inc. (NYSE: MDT) in long-term patient follow-up...

147 - Four Colorado Institutions Launch Statewide Science and Technology Education Collaborative

DENVER-(Business Wire)-September 21, 2009 - Four Colorado institutions: Metropolitan State College of Denver, Colorado School of Mines, Community College of Denver, and Cherry Creek School District, have formed an unprecedented alliance – the Colorado Academy for the Development of STEM-related...

148 - In a Tough Economy, Bioscience Research, LLC Helps Eligible Westchester County Residents Access Depression Care at no Cost

MOUNT KISCO, N.Y.-(Business Wire)-September 21, 2009 - Psychiatrists at Bioscience Research, LLC, understand the mental health burden that can accompany unemployment and the day-to-day stress of looking for a new job or worrying about losing an existing job. In response to the area’s increased...

149 - HealthPartners Research Foundation receives $7.3 million in grants to study childhood obesity and hypertension

BLOOMINGTON, Minn.-(Business Wire)-September 21, 2009 - Three new HealthPartners Research Foundation studies will examine ways to prevent and treat childhood obesity and hypertension. One study will look at interventions to prevent obesity in children ages 5-9, another will focus on obesity...

150 - Makhteshim-Agan and Cibus Global Announce Strategic Agreement to Co-develop Proprietary Crop Protection Traits

TEL AVIV, Israel-(Business Wire)-September 21, 2009 - Makhteshim-Agan (MAI) and Cibus Global (CIBUS) announced today that they signed Strategic Development Alliance and Strategic Equity Alliance agreements. Under these agreements, MAI will invest up to $37 million over five years, based on certain...

151 - Performance Ingeo™ Meltblown Nonwovens Now a Demonstrated Reality

MINNETONKA, Minn.-(Business Wire)-September 21, 2009 - NatureWorks announced today at the 2009 International Nonwovens Technical Conference (INTC) being held in Denver that two grades of its low-carbon footprint Ingeo™ bioresin are now commercially available for the production of meltblown...

152 - Manhattan Scientifics, Inc. Announces Exclusive License with Carpenter Technology Corporation

LOS ALAMOS, N.M. and READING, Pa.-(Business Wire)-September 21, 2009 - Manhattan Scientifics, Inc. (OTCBB: MHTX) announced the signing of a contract with Carpenter Technology Corporation (NYSE: CRS), wherein Carpenter will fully develop, manufacture and market a new class of high strength metals...

153 - Sloning Closes Growth Financing Round Led by LBBW Venture

PUCHHEIM, Germany-(Business Wire)-September 21, 2009 - Sloning BioTechnology GmbH, the worldwide leading supplier of combinatorial gene libraries, received additional investments from all of its institutional shareholders: HBM BioVentures, LBBW Venture, DEWB and KfW to finance the company’s...

154 - Medtronic, Inc. Launches Innovative Cement Delivery System for KYPHON® Balloon Kyphoplasty

MINNEAPOLIS-(Business Wire)-September 21, 2009 - Medtronic, Inc. (NYSE:MDT), today announced the full U.S. launch of the KYPHON Cement Delivery System (CDS), adding an innovative bone cement delivery option to its extensive KYPHON Balloon Kyphoplasty product portfolio for the treatment of...

155 - Landec Corporation Announces Upcoming Events and Annual Report

MENLO PARK, Calif.-(Business Wire)-September 21, 2009 - Landec Corporation (Nasdaq:LNDC), a materials science company that develops and markets patented temperature-activated and other specialty polymer products for a variety of food, agriculture and licensed partner applications, today announced...

156 - StemCells, Inc. Announces Participation in 2009 World Stem Cell Summit

PALO ALTO, Calif.-(Business Wire)-September 21, 2009 - StemCells, Inc. (NASDAQ:STEM) announced today its participation in the 2009 World Stem Cell Summit to be held September 21 – 23 in Baltimore, Maryland. The World Stem Cell Summit brings together founding visionary researchers, clinicians...

157 - NABsys Expands Leadership Team with Appointment of Stan Rose to Board of Directors

PROVIDENCE, R.I.-(Business Wire)-September 21, 2009 - NABsys Inc. announced today that industry veteran and serial entrepreneur, Stan Rose, Ph.D., has been appointed to the company’s board of directors. Dr. Rose is the most recent addition to the leadership team at NABsys, which recently raised $4...

158 - Dicerna Pharmaceuticals to Present at 2009 Biologics Drug Delivery & Beyond Conference

WATERTOWN, Mass.-(Business Wire)-September 21, 2009 - Dicerna Pharmaceuticals, Inc., a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology™ and dicer substrate RNAi molecules, today announced that Sujit K. Basu...

159 - Joule Biotechnologies Elects Graham Allison to Board of Directors

CAMBRIDGE, Mass.-(Business Wire)-September 21, 2009 - Joule Biotechnologies, Inc., an innovative bioengineering startup developing game-changing alternative energy solutions, today announced the election of Graham Allison to its board of directors. Dr. Allison is the Douglas Dillon professor and...

160 - Vivakor Achieves Major Advancement in Design and Performance of Its Superior Cryopreservation Consumables; Improves 2010 Revenues Projections for VivaThermic Division

CORALVILLE, Iowa-(Business Wire)-September 21, 2009 - Vivakor, Inc. (OTCBB: VIVK) today announced the successful testing results of its new self-sealing caps for its VivaThermic vials. The unique self-sealing cap was designed to provide a superior seal, preventing leakage and cross-contamination...

161 - Cyntellect Unveils New CeligoTM Cytometer

SAN DIEGO-(Business Wire)-September 21, 2009 - Cyntellect, Inc., a privately-held life sciences company commercializing products to advance life science and stem cell research, biopharmaceutical production, and drug discovery, today unveiled its Celigo™ adherent cell cytometry system, the...

162 - Maxygen Announces Consummation of Joint Venture Transaction With Astellas

REDWOOD CITY, Calif.-(Business Wire)-September 21, 2009 - Maxygen, Inc. (Nasdaq:MAXY) today announced the consummation of the transactions contemplated by the previously announced joint venture agreement between Maxygen and Astellas Pharma Inc. Under the joint venture transaction, which closed on...

163 - TOLMAR and Zila Combine to Form Strong Dental Products Company

FORT COLLINS, Colo.-(Business Wire)-September 21, 2009 - On Friday, Sept. 18, 2009, the shareholders of Zila, Inc., a dental products company providing products for use in the prevention, detection and treatment of oral disease, approved the company’s merger with a subsidiary of TOLMAR Holding...

164 - PerkinElmer Launches Columbus™ 2.0 High Content Screening Platform for High-Volume Image Data Management and Analysis

BOSTON-(Business Wire)-September 21, 2009 - At the High Content Analysis East conference in Boston, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of the Columbus™ 2.0 platform, its flagship high content...

165 - Enzo Biochem and National Institutes of Health to Cooperate in Development of Enzo’s Novel Therapeutic Candidate for Treatment of Autoimmune Uveitis

NEW YORK-(Business Wire)-September 21, 2009 - Enzo Biochem, Inc. (NYSE: ENZ), announced today that it had entered into a Cooperative Research and Development Agreement (CRADA) with the National Eye Institute, part of the National Institute of Health, to conduct a human clinical trial of Optiquel...

166 - Pacific Biosciences Expands Mission and Prepares for Commercialization

MENLO PARK, Calif.-(Business Wire)-September 21, 2009 - Pacific Biosciences, a private company developing a disruptive technology platform for real-time detection of biological events at single molecule resolution, today provided a number of updates to its commercial strategy and progress. First...

167 - David Bearss Resigns as Chief Scientific Officer to Join Huntsman Cancer Institute as Co-director of Center for Investigational Therapeutics

DUBLIN, Calif.-(Business Wire)-September 21, 2009 - SuperGen Inc. (Nasdaq:SUPG) announced that, effective October 16, 2009, David Bearss, Ph.D., will resign as SuperGen’s Chief Scientific Officer, and be engaged as a long-term biology consultant to the Company. In addition, Dr. Bearss will...

168 - Research and Markets: Coherent States in Quantum Physics

DUBLIN-(Business Wire)-September 21, 2009 - Research and Markets -Material D. Wigner-Eckart Theorem for CS quantized Spin Harmonics E. Symmetrization of the Commutator Bibliography For more information visit http://www.researchandmarkets.com/research/8cfe37/coherent_states_in

169 - German Clinical Microbiology Laboratories Extend Their Accreditation to Include Bruker´s MALDI Biotyper Molecular Identification Solution

GOETTINGEN, Germany-(Business Wire)-September 21, 2009 - At the 61st Annual Meeting of the German Society for Hygiene and Microbiology on September 20-23, 2009 in Goettingen, Bruker Daltonics announces that three major German private clinical microbiology laboratories have extended their...

170 - Labor Becker-Olgemoeller Selects Bruker´s MALDI Biotyper as an Integrated Multi-Workstation Solution for Microbial Identification

GÖTTINGEN, Germany-(Business Wire)-September 21, 2009 - At the 61st Annual Meeting of the German Society for Hygiene and Microbiology, Bruker Daltonics announces that Labor Becker-Olgemöller in Munich has installed the Bruker MALDI Biotyper as their next-generation, rapid molecular microbial...

171 - Experts Available to Discuss: Who Says Americans Are Too Fat?

-(Business Wire)-September 18, 2009 - ExpertSource: TOPIC: As a recent Newsweek article states, "it's hardly clear that there actually is an obesity epidemic, or that fat people are at greater risk of death than people of normal weight, or that weight loss—relentlessly promoted by public-health...

172 - PHT and Lionbridge Present Webinar on Strategies for Conducting Successful Clinical Trials in Emerging Markets

BOSTON & WALTHAM, Mass.-(Business Wire)-September 18, 2009 - PHT Corporation and Lionbridge Technologies, Inc. (NASDAQ:LIOX) are sponsoring a webinar to reveal the crucial elements required to avoid operational complexities and financial risk when conducting clinical trials in emerging...

173 - Experts Available to Discuss: Swine Flu Might Be Even More Contagious; Tests Show People 'Shed' the Swine Flu Virus for Days Longer Than First Thought

-(Business Wire)-September 18, 2009 - ExpertSource: TOPIC: ABC News and other outlets are reporting that two studies released on Tuesday suggest that people infected with the H1N1 virus continue to shed virus after the point where current recommendations say they can resume their normal...

174 - Metabasis Therapeutics Receives Notice of Noncompliance with Nasdaq Listing Requirements

SAN DIEGO-(Business Wire)-September 18, 2009 - Metabasis Therapeutics, Inc. (Nasdaq: MBRX) announced today that on September 15, 2009, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”), notifying the Company that based upon the closing...

175 - KCI Sponsors Georgetown Diabetic Limb Salvage Conference Symposium Featuring Top Limb Preservation Experts

SAN ANTONIO-(Business Wire)-September 18, 2009 - Kinetic Concepts, Inc. (KCI) will sponsor a CME-accredited panel discussion, “The Role of NPWT in the Team Approach to Limb Salvage: Case Studies,” at the 3rd Annual Georgetown Diabetic Limb Salvage conference September 24-26. At the symposium...

176 - Medtronic Expects New Data on Drug-Eluting Stents and Transcatheter Heart Valves to Feature at TCT 2009

MINNEAPOLIS-(Business Wire)-September 18, 2009 - Expecting new data on drug-eluting stents and transcatheter heart valves to feature prominently at Transcatheter Cardiovascular Therapeutics (TCT) 2009 next week in San Francisco, Medtronic, Inc. (NYSE: MDT), today announced plans to showcase its...

177 - Statement by Kathleen Sebelius Secretary of Health and Human Services Regarding the Selection of Dr. Francis Collins as a National Medal of Science Recipient

WASHINGTON-(Business Wire)-September 18, 2009 - I applaud President Obama’s selection of our National Institutes of Health (NIH) Director Dr. Francis Collins as one of this year’s recipients of the National Medal of Science. As Director of the NIH, Dr. Collins is continuing the work that has...

178 - Sports Legends and Broadcast Personalities Headline Multiple Myeloma Research Foundation’s 13th Annual Fall Gala

NORWALK, Conn.-(Business Wire)-September 18, 2009 - The Multiple Myeloma Research Foundation (MMRF) today announced that American figure skating legend and Olympic gold medalist Scott Hamilton will serve as Master of Ceremonies at the 13th Annual MMRF Fall Gala, on Saturday, Oct. 24, 2009, at the...

179 - From Ancient Bones to the Future of DNA Technologies: Forensic Experts Gather for Exclusive Symposium on Human Identity

MADISON, Wis.-(Business Wire)-September 18, 2009 - The 20th International Symposium on Human Identification will highlight advances in DNA technology and explore controversial issues brought about by the expanded power and use of DNA typing. Over 600 forensic analysts from around the world will...

180 - Hyperion Therapeutics to Present at UBS 2009 Global Life Sciences Conference

SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 18, 2009 - Hyperion Therapeutics, Inc. today announced that Donald Santel, Chief Executive Officer, will present at the UBS 2009 Global Life Sciences Conference on Wednesday September 23, 2009 at 4:30 pm ET. The conference will be held at the...

181 - The Scripps Research Institute and IAVI Host Leading Scientists Searching for New Ways to Produce an HIV/AIDS Vaccine

-(Business Wire)-September 18, 2009 - MEDIA ADVISORY:   WHAT:   International Symposium “Toward a Vaccine that Elicits Broadly Neutralizing Antibodies against HIV.” More than 70 leading HIV/AIDS vaccine researchers will gather to discuss recent scientific advances in the quest to develop an...

182 - GTC Biotherapeutics Receives NASDAQ Notice; Intends to Request Hearing

FRAMINGHAM, Mass.-(Business Wire)-September 18, 2009 - GTC Biotherapeutics, Inc.’s ("GTC", NASDAQ: GTCB) received a letter from the Listing Qualifications Staff of The NASDAQ Stock Market (the “Staff Determination”) on September 17, 2009, indicating that unless GTC requests a hearing before...

183 - Dr. Kevin Krenitsky, President of Enzo Clinical Labs, to Present At 27th Annual Lab Institute

NEW YORK-(Business Wire)-September 18, 2009 - Enzo Biochem, Inc. (NYSE:ENZ) announced today that Kevin Krenitsky, MD, President of Enzo Clinical Labs, will present at the 27th Annual Lab Institute ’09, sponsored by Washington G2 Reports, on September 23, 2009 in Arlington, Virginia. Dr...

184 - Research and Markets: Biophysico-Chemical Processes Involving Natural Nonliving Organic Matter in Environmental Systems - Now Available

DUBLIN-(Business Wire)-September 18, 2009 - Research and Markets . For more information visit http://www.researchandmarkets.com/research/a1ae37/biophysicochemica

185 - WWF report: Industrial biotech can save the world up to 2.5 billion tons of CO2 per year

FRANKLINTON, N.C.-(Business Wire)-September 18, 2009 - The WWF report Industrial biotechnology – more than green fuel in a dirty economy?, which has been published today, concludes that industrial biotechnology can provide dramatic reductions in greenhouse gas emissions and provide strong progress...

186 - Bruker Corporation Announces Proposed Secondary Offering

BILLERICA, Mass.-(Business Wire)-September 18, 2009 - Bruker Corporation (NASDAQ: BRKR) today announced an underwritten public secondary offering of 12,000,000 shares of its common stock by two members of the Laukien family not involved in the Company’s business. The selling stockholders also...

187 - 2007-2009 Taiwan-Israel Joint Final Report Workshop, Oct 13 in NCKU

TAINAN, Taiwan-(Business Wire)-September 18, 2009 - The National Science Council of Taiwan and the Ministry of Science & Technology of Israel will together hold “2007-2009 Taiwan-Israel Joint Final Report Workshop” on October 13th at the 3rd Lecture Hall of International Conference Hall...

188 - Universal Detection Technology Addresses Bioterrorism Threat to National Security at ASIS 2009

LOS ANGELES-(Business Wire)-September 17, 2009 - Universal Detection Technology (www.udetection.com)(OTCBB: UNDT), a developer of early-warning monitoring technologies and counter-terrorism training programs to protect people from bioterrorism and other infectious health threats, announced today...

189 - Seattle Genetics to Present at UBS Global Life Sciences Conference

BOTHELL, Wash.-(Business Wire)-September 17, 2009 - Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that Clay B. Siegall, Ph.D., President and Chief Executive Officer, will present at the 2009 UBS Global Life Sciences Conference on Tuesday, September 22, 2009, at 2:00 p.m. Eastern Time. The...

190 - Burnham Institute for Medical Research and Duke University Sarah W. Stedman Nutrition and Metabolism Center Announce Metabolic Research Collaboration

ORLANDO, Fla. & DURHAM, N.C.-(Business Wire)-September 17, 2009 - A new collaborative research program that will use the power of metabolomic profiling to help advance the concept of personalized medicine was announced September 17, 2009 by the Burnham Institute for Medical Research and the...

191 - Fluidigm’s Upcoming Stem Cell Culture Chip to Speed Development, Reduce Complexity and Lower Costs

SOUTH SAN FRANCISCO, Calif.-(Business Wire)-September 17, 2009 - Fluidigm will provide the latest updates for its upcoming Stem Cell Culture Chip at the World Stem Cell Summit being held in Baltimore on September 21 – 23. This specialized integrated fluidic circuit will enable a variety of cell...

192 - The Bioscience Conference That Thinks Globally

COLUMBUS, Ohio-(Business Wire)-September 17, 2009 - On October 1 the 2009 BioOhio Annual Conference, “BioGPS: Global Positioning for Success,” will focus on the globalization of bioscience and the inherent growth opportunities for Ohio organizations. Conference topics will range from exporting...

193 - China Education Technology, Inc. Has Been Verified as a High-Tech Company by the Ministry of Science and Technology of China and State Administration of Taxation

GUANGZHOU, China-(Business Wire)-September 17, 2009 - China Education Technology Inc. (OTC Bulletin Board:CEDT)(“CEDT”), a Chinese leader in school lab experiment products, today announced that it has been verified as a High-Tech Company by the Ministry of Science and Technology of China and...

194 - Introducing Cibus Global: Leading Agricultural Biotech Firm Rebrands to Reflect Enhanced International Focus

SAN DIEGO-(Business Wire)-September 17, 2009 - Cibus, a leading plant trait development technology company, is now Cibus Global. Announced today by Cibus Global President Keith Walker, Ph.D., the shift marks a new age for the company, with an international operating structure and a continued focus...

195 - WBBA Fifth Annual Governor’s Life Sciences Summit

SEATTLE-(Business Wire)-September 17, 2009 - The Washington Biotechnology & Biomedical Association (WBBA), life science leaders and experts, and Washington State Governor Christine Gregoire join forces to mark the industry’s progress, discuss critical issues facing the Life Science sector...

196 - Seafarer Exploration Announces Purchase of Hand Held Magnetometer

NEW YORK-(Business Wire)-September 17, 2009 - Seafarer Exploration Corp. (OTCBB:SFRX) today announced the purchase of a hand held SM10 Magnetometer. Jim Sinclair, the Company Archaeologist stated in a letter to the Board that, “the hand held magnetometer will allow divers to precisely locate the...

197 - Enzo Biochem’s Life Sciences Unit Introduces Novel System for Simultaneous Live-Cell Imaging of Nuclear Components

FARMINGDALE, N.Y.-(Business Wire)-September 17, 2009 - Enzo Life Sciences, a division of Enzo Biochem, Inc. (NYSE:ENZ), has added a novel new system to its CELLestial™ line of live cell analysis products, providing expanded capability to simultaneously image both the nucleus and the nucleolus in...

198 - NextBio Secures $8 Million in Series C Venture Funding

CUPERTINO, Calif.-(Business Wire)-September 17, 2009 - NextBio, provider of an innovative platform that enables life science researchers to search, discover, and share knowledge locked within public and proprietary data, today announced that it has closed a $8 million Series C round of financing led...

199 - New Research Shows Direct Link Between Soda and Obesity

DAVIS, Calif.-(Business Wire)-September 17, 2009 - While health officials have long suspected the link between obesity and soda consumption, research released today provides the first scientific evidence of the potent role soda and other sugar-sweetened beverages play in fueling California’s...

200 - Seaside Therapeutics Secures $30 Million Financing

CAMBRIDGE, Mass.-(Business Wire)-September 17, 2009 - Seaside Therapeutics LLC today announced that it has secured $30 million in financing from a private, family investment firm which is committed to advancing research in the field of autism and Fragile X Syndrome. The financing will be used to...

Search Our News Using Google Search

Can't find what you want? Try using Google:

	Enter your search terms Submit search form
	Web www.digital50.com

	Subscribe to our RSS feeds and get press releases delivered daily
	Subscribe to Business Press Releases in up to 210 Industries
	Add the DiGiTAL50 Search to your Site, FREE!